Eight people are diagnosed with acute myeloid leukaemia in the UK each day, accounting for over 2000 deaths each year. But a new potential therapeutic target has been uncovered, which could help improve future treatments. Scientists from Cardiff University have identified a biological molecule, Gata2, which could provide new avenues for developing effective therapies for… Read More »
Researchers from University of California, San Francisco and the University of Washington have developed a new artificial protein switch, dubbed LOCKR. Their work demonstrates that the new switch can be used to control many intracellular processes, including mediating molecular traffic inside a cell, degrading specific proteins, and causing a cell to self-destruct. This exciting development… Read More »
Amicus Therapeutics has already forked over $ 100 million for 10 gene therapies. It is building a new R&D operation to advance them. But when it comes to manufacturing, it is turning to a CDMO. The New Jersey-based biotech today announced it has an arrangement with Thermo Fisher Scientific’s gene therapy unit to provide clinical… Read More »
Prostate cancer has historically been more common, more aggressive and more lethal in African-American men compared with other racial groups. But new findings presented at the 2019 Genitourinary Cancers Symposium reveal that Black men with advanced prostate cancer treated with newer hormone therapies lived 20 percent longer than their white counterparts, reports the American Society… Read More »